Austin biotech firm Biostable raises $4.2 million Original article at statesman.com Austin-based heart valve device company Biostable Science and Engineering said it is looking to strengthen its marketing efforts following a $4.2 million funding round. [...]
BioStable Science & Engineering Announces Initial Closing of Series C Equity Round View the original article on BusinessWire AUSTIN, Texas--(BUSINESS WIRE)--BioStable Science & Engineering, a medical technology company focused on products for aortic valve repair [...]
After a successful deployment at University of California Irvine, Phynd is now the selected data management vendor for University of California San Diego.
Rex Health Ventures invests in BardyDX's $35.5M Series B Round to further advance cardiac care.
Phynd Technologies announces the close of an $8 million Series B including new strategic healthcare investors.
UNC's clinically integrated network delivers high-quality, cost effective care to patients with help from Phynd
